LHRH-conjugated lytic peptides directly target prostate cancer cells (Q30497581)

28 September 2017

LHRH-conjugated lytic peptides directly target prostate cancer cells (English)

1 reference

28 September 2017

1 reference

Clayton Yates

1

1 reference

28 September 2017

Starlette Sharp

2

1 reference

28 September 2017

Jacqueline Jones

3

1 reference

28 September 2017

Daphne Topps

4

1 reference

28 September 2017

Mathew Coleman

5

1 reference

28 September 2017

Ritu Aneja

6

1 reference

28 September 2017

Jesse Jaynes

7

1 reference

28 September 2017

Timothy Turner

8

1 reference

28 September 2017

language of work or name

English

0 references

publication date

30 September 2010

1 reference

28 September 2017

Biochemical Pharmacology

1 reference

28 September 2017

81

1 reference

28 September 2017

1

1 reference

28 September 2017

104-110

1 reference

Tumor-Stromal Interactions Influence Radiation Sensitivity in Epithelial- versus Mesenchymal-Like Prostate Cancer Cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997383

Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997383

Novel three-dimensional organotypic liver bioreactor to directly visualize early events in metastatic progression

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997383

Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997383

Conjugates of lytic peptides and LHRH or betaCG target and cause necrosis of prostate cancers and metastases

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997383

Gonadotropins and prostate cancer: revisited.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997383

Targeting breast and prostate cancers through their hormone receptors

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997383

Targeted ablation of prostate carcinoma cells through LH receptor using Hecate-CGbeta conjugate: functional characteristic and molecular mechanism of cell death pathway.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997383

20 June 2018

Cancer statistics, 2004

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997383

Membrane disrupting lytic peptide conjugates destroy hormone dependent and independent breast cancer cells in vitro and in vivo

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997383

In vitro microbicidal activities of cecropin peptides D2A21 and D4E1 and gel formulations containing 0.1 to 2% D2A21 against Chlamydia trachomatis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997383

Growth-inhibitory effects of luteinizing hormone-releasing hormone (LHRH) agonists on xenografts of the DU 145 human androgen-independent prostate cancer cell line in nude mice.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997383

Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997383

Peptide antibiotics and their role in innate immunity

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997383

In vitro cytocidal effect of lytic peptides on several transformed mammalian cell lines.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997383

The effects of gonadotrophin releasing hormone analogues in prostate cancer are mediated through specific tumour receptors

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997383

Gonadotrophin-releasing hormone: physiological significance and relevance to cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997383

Isolation of a human prostate carcinoma cell line (DU 145)

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997383

Establishment and characterization of a human prostatic carcinoma cell line (PC-3)

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997383

Targeted destruction of prostate cancer cells and xenografts by lytic peptide-betaLH conjugates.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997383

Treatment of infected wounds with the antimicrobial peptide D2A21.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997383

Racial variation in CAG repeat lengths within the androgen receptor gene among prostate cancer patients of lower socioeconomic status

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997383

The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997383

The LNCaP cell line--a new model for studies on human prostatic carcinoma

26 November 2018

1 reference

12 December 2020

Peptidyl membrane-interactive molecules are cytotoxic to prostatic cancer cells in vitro

1 reference

12 December 2020

EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells

1 reference

12 December 2020

Human prostate cancer cells and xenografts are targeted and destroyed through luteinizing hormone releasing hormone receptors

1 reference

12 December 2020

In vitro cytocidal effect of novel lytic peptides on Plasmodium falciparum and Trypanosoma cruzi

1 reference

12 December 2020

Efficacy of a synthetic lytic peptide in the treatment of prostate cancer

1 reference

12 December 2020

Destruction of breast cancers and their metastases by lytic peptide conjugates in vitro and in vivo

1 reference

12 December 2020

High incidence of receptors for luteinizing hormone-releasing hormone (LHRH) and LHRH receptor gene expression in human prostate cancers

1 reference

12 December 2020

Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men

1 reference

12 December 2020

10.1016/J.BCP.2010.09.015

Identifiers

DOI

1 reference

28 September 2017

1 reference

28 September 2017

PubMed publication ID

20869347

1 reference